Nexgel, Inc. ( (NXGL) ) has released its Q2 earnings. Here is a breakdown of the information Nexgel, Inc. presented to its investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
NEXGEL, Inc., based in Langhorne, Pennsylvania, is a prominent provider of healthcare, beauty, and over-the-counter products, specializing in ultra-gentle, high-water-content hydrogels for consumer and healthcare applications. The company has been in the business of developing and manufacturing these hydrogels for over two decades.
In its latest earnings report for the second quarter of 2025, NEXGEL, Inc. announced a significant increase in revenue, reaching $2.88 million, which marks a 100.3% rise compared to the same period last year. The company also reported a substantial improvement in gross profit margins, which increased to 43.6% from 20.3% in the previous year.
Key financial highlights from the report include a gross profit of $1.26 million, up from $0.29 million in the second quarter of 2024. The net loss attributable to NEXGEL stockholders was reduced to $0.67 million from $0.89 million in the same period last year. The company also reported a decrease in its adjusted EBITDA loss to $0.42 million, showing a steady improvement in financial performance.
Looking ahead, NEXGEL remains optimistic about its growth prospects for the remainder of 2025. The company has reiterated its revenue guidance of $13 million for the year and aims to achieve positive EBITDA. Management is confident in the potential for significant growth opportunities, driven by new consumer product launches and an expanded contract manufacturing customer base.